S100A2 and pancreatic neoplasm: We found that the high expression of S100A2/A3/A4/A5/A6/A10/A11/A13/A14/A16/P in pancreatic cancer was positively correlated with TP53 mutation, while the high expression of S100A1/A12/B/Z was negatively correlated with TP53 mutation (Figure 5).